137 related articles for article (PubMed ID: 22081781)
1. Risk Prediction for Prostate Cancer Recurrence Through Regularized Estimation with Simultaneous Adjustment for Nonlinear Clinical Effects.
Long Q; Chung M; Moreno CS; Johnson BA
Ann Appl Stat; 2011 Sep; 5(3):2003-2023. PubMed ID: 22081781
[TBL] [Abstract][Full Text] [Related]
2. Rank-based estimation in the {ell}1-regularized partly linear model for censored outcomes with application to integrated analyses of clinical predictors and gene expression data.
Johnson BA
Biostatistics; 2009 Oct; 10(4):659-66. PubMed ID: 19553356
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Addressing issues associated with evaluating prediction models for survival endpoints based on the concordance statistic.
Wang M; Long Q
Biometrics; 2016 Sep; 72(3):897-906. PubMed ID: 26756274
[TBL] [Abstract][Full Text] [Related]
5. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical Feature Selection Incorporating Known and Novel Biological Information: Identifying Genomic Features Related to Prostate Cancer Recurrence.
Zhao Y; Chung M; Johnson BA; Moreno CS; Long Q
J Am Stat Assoc; 2016; 111(516):1427-1439. PubMed ID: 28435175
[TBL] [Abstract][Full Text] [Related]
7. A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 Trial.
Parr H; Porta N; Tree AC; Dearnaley D; Hall E
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1055-1068. PubMed ID: 36822374
[TBL] [Abstract][Full Text] [Related]
8. PSA density does not improve predictive accuracy of the UCSF-CAPRA score.
Parker R; Bell A; Chang K; Greenberg S; Washington SL; Cowan JE; Carroll PR; Cooperberg MR
Prostate; 2023 Jul; 83(10):922-928. PubMed ID: 37078628
[TBL] [Abstract][Full Text] [Related]
9. Stability selection for lasso, ridge and elastic net implemented with AFT models.
Khan MHR; Bhadra A; Howlader T
Stat Appl Genet Mol Biol; 2019 Oct; 18(5):. PubMed ID: 31586968
[TBL] [Abstract][Full Text] [Related]
10. On estimation for accelerated failure time models with small or rare event survival data.
Alam TF; Rahman MS; Bari W
BMC Med Res Methodol; 2022 Jun; 22(1):169. PubMed ID: 35689190
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical Trial.
Finelli A; Beer TM; Chowdhury S; Evans CP; Fizazi K; Higano CS; Kim J; Martin L; Saad F; Saarela O
JAMA Netw Open; 2021 Jun; 4(6):e2112426. PubMed ID: 34129025
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Predictive Factors, and Prediction Nomograms for
Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M
Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059
[TBL] [Abstract][Full Text] [Related]
13. Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data.
Bastien P; Bertrand F; Meyer N; Maumy-Bertrand M
Bioinformatics; 2015 Feb; 31(3):397-404. PubMed ID: 25286920
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.
Budäus L; Isbarn H; Tennstedt P; Salomon G; Schlomm T; Steuber T; Haese A; Chun F; Fisch M; Michl U; Heinzer H; Huland H; Graefen M
BJU Int; 2012 Dec; 110(11):1714-20. PubMed ID: 22520619
[TBL] [Abstract][Full Text] [Related]
16. Variable selection for high-dimensional partly linear additive Cox model with application to Alzheimer's disease.
Wu Q; Zhao H; Zhu L; Sun J
Stat Med; 2020 Oct; 39(23):3120-3134. PubMed ID: 32652699
[TBL] [Abstract][Full Text] [Related]
17. Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint Approaches.
Desmée S; Mentré F; Veyrat-Follet C; Guedj J
AAPS J; 2015 May; 17(3):691-9. PubMed ID: 25739818
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer.
Feng F; Zhong YX; Chen Y; Lin FX; Huang JH; Mai Y; Zhao PP; Wei W; Zhu HC; Xu ZP
BMC Urol; 2023 Jul; 23(1):120. PubMed ID: 37452418
[TBL] [Abstract][Full Text] [Related]
19. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
20. Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach.
Devaux A; Genuer R; Peres K; Proust-Lima C
BMC Med Res Methodol; 2022 Jul; 22(1):188. PubMed ID: 35818025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
